Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

Bone Marrow Aspirates Alone without a Trephine Biopsy May be Insufficient for the Detection of Residual Leukemia Following Intensive Chemotherapy for the Treatment of Acute Myeloid Leukemia

Lalit Saini, MD, Robert Turner, MD, Loree Larratt, MD, Joseph Brandwein, MD, Marlene Ann Hamilton, MD, Anthea Peters, MD MSc, FRCPC, Cynthia M Wu, MD FRCPC, Nancy Zhu, MD, Jeffery M. Patterson, MD, Lauren Bolster, MD, Michael Mant, MD, Bruce Ritchie, MD, Elena Liew, MD, Imran Mirza, MD FRCPC, Graeme R. Quest, MDMSc, Susan Nahirniak, Sunita Gosh, PhD, P.Stat., P.Stat, Irwindeep Sandhu, MD FRCPC

Blood (2014) 124 (21): 2336.

https://doi.org/10.1182/blood.V124.21.2336.2336

Published: 2014

Journal Articles

The FLAG Chemotherapy Regimen Is an Alternative to Anthracycline Based Therapy for the Treatment of Acute Myeloid Leukemia for Patients with Multiple Co-Morbidities or Preexisting Cardiac Disease

Lalit Saini, MD, Robert Turner, MD, Loree Larratt, MD, Joseph Brandwein, MD, Marlene Ann Hamilton, MD, Anthea Peters, MD MSc, FRCPC, Cynthia M. Wu, MD FRCPC, Nancy Zhu, MD, Jeffery M. Patterson, MD, Lauren Bolster, MD, Michael Mant, MD, Bruce Ritchie, MD, Elena Liew, MD, Imran Mirza, MD FRCPC, Graeme R. Quest, MDMSc, Sunita Gosh, PhD, P.Stat., P.Stat, Irwindeep Sandhu, MD FRCPC

Blood (2014) 124 (21): 961.

https://doi.org/10.1182/blood.V124.21.961.961

Published: 2014

Journal Articles

Autologous Stem Cell Transplantation Improves Survival for Patients with Follicular Lymphoma in First or Second Relapse: Results of a Comparative Effectiveness Instrumental Variable Analysis

Danielle H. Oh, MB ChB, Qiuli Duan, MSc, Anthea Peters, MD MSc, FRCPC, Neil Chua, MD FRCPC, Douglas A. Stewart, MD FRCPC

Blood (2014) 124 (21): 3972.

https://doi.org/10.1182/blood.V124.21.3972.3972

Published: 2014

Journal Articles

Lymphopenia and EBER-Negativity Predict Poor Survival in Patients with Post-Transplant Lymphoproliferative Disorder (PTLD) Treated in the Rituximab Era

Anthea Peters, MD, MSc, FRCPC, Carolyn J Owen, MD, FRCPC, Karen Doucette, MD, FRCPC, Jutta Preiksaitis, MD, FRCPC

Blood (2011) 118 (21): 1645.

https://doi.org/10.1182/blood.V118.21.1645.1645

Published: 2011

Journal Articles

Autologous Stem Cell Transplantation Is a Curative Treatment Modality for Relapsed or Refractory Follicular Lymphoma, and Both Recent Rituximab Exposure and Follicular Lymphoma International Prognostic Index (FLIPI) 0–1 Scores Predict Improved Outcome

Anthea Peters, MD, MSc, FRCPC, James A Russell, MD, Andrew Daly, MD, FRCPC, Nizar J Bahlis, MD, Michelle Geddes, MD, Peter Duggan, MD, FRCPC, Mary Lynn Savoie, MD, FRCPC, Douglas A. Stewart, MD, FRCP

Blood (2010) 116 (21): 687.

https://doi.org/10.1182/blood.V116.21.687.687

Published: 2010

NARROW

Bone Marrow Aspirates Alone without a Trephine Biopsy May be Insufficient for the Detection of Residual Leukemia Following Intensive Chemotherapy for the Treatment of Acute Myeloid Leukemia

The FLAG Chemotherapy Regimen Is an Alternative to Anthracycline Based Therapy for the Treatment of Acute Myeloid Leukemia for Patients with Multiple Co-Morbidities or Preexisting Cardiac Disease

Autologous Stem Cell Transplantation Improves Survival for Patients with Follicular Lymphoma in First or Second Relapse: Results of a Comparative Effectiveness Instrumental Variable Analysis

Lymphopenia and EBER-Negativity Predict Poor Survival in Patients with Post-Transplant Lymphoproliferative Disorder (PTLD) Treated in the Rituximab Era

Autologous Stem Cell Transplantation Is a Curative Treatment Modality for Relapsed or Refractory Follicular Lymphoma, and Both Recent Rituximab Exposure and Follicular Lymphoma International Prognostic Index (FLIPI) 0–1 Scores Predict Improved Outcome

Email alerts

ASH Publications

American Society of Hematology

Bone Marrow Aspirates Alone without a Trephine Biopsy May be Insufficient for the Detection of Residual Leukemia Following Intensive Chemotherapy for the Treatment of Acute Myeloid Leukemia

The FLAG Chemotherapy Regimen Is an Alternative to Anthracycline Based Therapy for the Treatment of Acute Myeloid Leukemia for Patients with Multiple Co-Morbidities or Preexisting Cardiac Disease

Autologous Stem Cell Transplantation Improves Survival for Patients with Follicular Lymphoma in First or Second Relapse: Results of a Comparative Effectiveness Instrumental Variable Analysis

Lymphopenia and EBER-Negativity Predict Poor Survival in Patients with Post-Transplant Lymphoproliferative Disorder (PTLD) Treated in the Rituximab Era

Autologous Stem Cell Transplantation Is a Curative Treatment Modality for Relapsed or Refractory Follicular Lymphoma, and Both Recent Rituximab Exposure and Follicular Lymphoma International Prognostic Index (FLIPI) 0–1 Scores Predict Improved Outcome

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only